NURE · Nuveen Short-Term REIT ETF

Equity fundTracks an index0.36% fee$36mSince Dec 20, 2016SEC filings ↗

NURE tracks an index and returned +8.0% over the past year.

+8.0%
Total return, 1 year
0.36%
Expense ratio
30
Holdings
−14.7%
Below its high
WindowTotal returnS&P 500Gap to S&P 500Gap to Nasdaq-100
3M Jul 2 – Oct 2, 2026−9.5%+3.6%−13.1 pts−14.8 pts
6M Apr 2 – Oct 2, 2026+8.3%+17.9%−9.6 pts−20.1 pts
1Y Oct 2, 2025 – Oct 2, 2026+8.0%+16.2%−8.3 pts−16.3 pts
3Y Oct 3, 2023 – Oct 2, 2026+26.8%+89.3%−62.5 pts−88.0 pts
Since listing Dec 20, 2016 – Oct 2, 2026+65.8%+296.0%−230.2 pts−498.5 pts

NURE over each window to Oct 2, 2026. Every figure is an ETFIQ calculation. Source: ETFIQ.

NURE top ten by weight, 50.4% of its 30 equity positions, from the holdings filed for Jun 30, 2026. An index fund holds what the index holds, so this is the index. Source: the fund’s SEC filing.

Invitation Homes Inc 5.05%
UDR Inc 5.04%
American Homes 4 Rent 5.01%
Equity Residential 4.99%
Equity LifeStyle Properties Inc 4.97%
Mid-America Apartment Communities Inc 4.93%

In plain words

NURE tracks an index. Over the year to Oct 2, 2026 it returned +8.0% with distributions reinvested, against +16.2% for the S&P 500 and +24.3% for the Nasdaq-100. The prospectus expense ratio is 0.36% a year. By its holdings filed for Jun 30, 2026, 50% of the fund by weight is stocks the S&P 500 also holds, across 30 positions, with the top ten at 50.4%. It sat 14.7% below its high of Apr 20, 2022 on Oct 2, 2026.
What it tracksnot read by ETFIQ
Fund typeEquity fund
Category (ETFIQ)Stocks · U.S. real estate
Expense ratio (485BPOS XBRL, Apr 30, 2026)0.36%
Price$29.49
Listed sinceDec 20, 2016
Net assets (SEC filing, whole fund, as filed for Jun 30, 2026)$36m
Below its high (ETFIQ)−14.7%
Holdings30
Top ten weight50.4%
Holdings as of (SEC N-PORT)Jun 30, 2026
Already in the S&P 500, by weight (ETFIQ)49.7%
Active share vs the S&P 500 (ETFIQ)99.7%
Already in the Nasdaq-100, by weight (ETFIQ)0.0%
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

Questions people ask about NURE

How has NURE performed?
Over the year to Oct 2, 2026, NURE returned +8.0% with distributions reinvested, against +16.2% for the S&P 500. Over three years the figure is +26.8%.
What does NURE cost?
The prospectus expense ratio is 0.36% a year.
What does NURE hold?
30 positions as filed for Jun 30, 2026, with the top ten at 50.4% of the fund. 50% of its weight is in stocks the S&P 500 also holds.
How far is NURE below its high?
14.7% below its high of Apr 20, 2022, measured on the reinvested series to Oct 2, 2026.
Sources and dates
Prices, NURE and S&P 500Tiingo end-of-day · Oct 2, 2026
Net assets, $36mSEC filing, whole fund · Jun 30, 2026

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

ETFIQ covers core, leveraged and inverse, buffer, thematic, option-income, alternatives and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources

Cite this page

ETFIQ, NURE, core fund, data as of Oct 2, 2026. https://etfiq.com/funds/nure

Free to use with attribution; the underlying files are at Open data.